Get started
Work

Supplementary Table 2 from Induction of Robust Type-I CD8+ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC

Year: 2023
Type: supplementary-materials
Abstract: Supplementary Table 2. Comparison of ELISPOT responses between the current study and our recent study in pediatric glioma patients
DOI: 10.1158/1078-0432.22461569
Authors: Hideho Okada, Lisa H. Butterfield, Ronald L. Hamilton, Aki Hoji, Masashi Sakaki, Brian J. Ahn, Gary Kohanbash, Jan Drappatz, Johnathan Engh, Nduka Amankulor, Mark O. Lively, Michael D. Chan, Andres M. Salazar, Edward G. Shaw, Douglas M. Potter, Frank S. Lieberman
Language: English
Subfield: Immunology
Open Access status: gold
OpenAlex ID: W4361885370
Cites:
Cited by:
Related to: 10